• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Regeneron Highlights Plug-and-Play Oncology Strategy at ESMO

cafead

Administrator
Staff member
  • cafead   Sep 12, 2022 at 11:42: PM
via Regeneron’s oncology strategy is to improve checkpoint inhibitor treatments with combination therapies – centered around Libtayo – according to a pipeline overview presented to investors Monday morning.

article source
 

<